LCM
IRON icon

Legato Capital Management’s Disc Medicine IRON Stock Holding History

Legato Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,248
Closed -$655K – 813
2025
Q4 		$655K Sell
8,248
-3,039
-27% -$257K 0.06% 473
2025
Q3 		$746K Buy
11,287
+4,059
+56% +$241K 0.08% 369
2025
Q2 		$383K Buy
+7,228
New +$340K 0.05% 473
2024
Q2 		– Sell
-7,872
Closed -$490K – 598
2024
Q1 		$490K Buy
7,872
+2,599
+49% +$169K 0.06% 447
2023
Q4 		$305K Buy
+5,273
New +$270K 0.04% 492

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Legato Capital Management's IRON Position: Q1 2026 in Review

Legato Capital Management sold out of Disc Medicine (IRON) in Q1 2026, closing a stake of 8,248 shares — an estimated $655K sold.

Legato Capital Management first reported a position in IRON in Q4 2023 and held it in 5 quarters. The position peaked at $746K in Q3 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Legato Capital Management reported no remaining Disc Medicine position as of Q1 2026 after selling out during the quarter.
  • Legato Capital Management sold 8,248 Disc Medicine shares in Q1 2026, an estimated $655K.
  • Legato Capital Management first reported a position in Disc Medicine in Q4 2023 and held it in 5 quarters.
  • Legato Capital Management's Disc Medicine position peaked at $746K in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.